Enhancing angiogenesis in collagen matrices by covalent incorporation of VEGF - PubMed (original) (raw)
Enhancing angiogenesis in collagen matrices by covalent incorporation of VEGF
S Koch et al. J Mater Sci Mater Med. 2006 Aug.
Abstract
Since the survival of ingrowing cells in biomaterials for regenerative processes largely depends on the supply of nutrients and oxygen, angiogenesis plays an important role in the development of new materials for tissue engineering. In this study we investigated the possibility of enhancing the angiogenic properties of collagen matrices by covalent incorporation of the vascular endothelial growth factor (VEGF). In a previous paper we already reported the use of homo- and heterobifunctional cross-linking agents for modifying collagen matrices [1]. In the present work the angiogenic growth factor was linked to the collagen with the homobifunctional cross-linker disuccinimidyldisuccinatepolyethyleneglycol (SS-PEG-SS) in a two step procedure. The efficiency of the first reaction step-the reaction of SS-PEG-SS with VEGF--was evaluated by western blot analysis. After 10 minutes virtually all of the dimeric molecules VEGF were on average modified by conjugation with 1 cross-linking molecule. The biological activity of the conjugate was investigated by exposing endothelial cells to non-modified VEGF and to VEGF conjugated to the cross-linker. The conjugation only had a limited effect on the mitogenic activity of VEGF. We therefore applied the cross-linking reaction to the VEGF-collagen system. In a first approach the changes were evaluated by the in vitro exposure of HUVECs to non-modified matrices, to matrices in which the VEGF was simply admixed and to matrices in which the VEGF was covalently incorporated. The angiogenic properties were evaluated in vivo with the chorioallantois membrane model. In this assay the chorioallantois membrane of the chicken embryo was exposed to the same set of matrices. The covalent incorporation of VEGF has a small but significant effect both on the formation of microvessels in the chorioallantois membrane and the tissue ingrowth into the implant. The covalent incorporation of angiogenic growth factors may thus be considered as a promising approach for enhancing the angiogenic capabilities of collagen matrices. Also the cross-linking with the homobifunctional cross-linking agent has a positive effect on the angiogenic potential of the collagen matrices.
Similar articles
- The effect of cross-linking of collagen matrices on their angiogenic capability.
Yao C, Markowicz M, Pallua N, Noah EM, Steffens G. Yao C, et al. Biomaterials. 2008 Jan;29(1):66-74. doi: 10.1016/j.biomaterials.2007.08.049. Biomaterials. 2008. PMID: 17935778 - Modulation of angiogenic potential of collagen matrices by covalent incorporation of heparin and loading with vascular endothelial growth factor.
Steffens GC, Yao C, Prével P, Markowicz M, Schenck P, Noah EM, Pallua N. Steffens GC, et al. Tissue Eng. 2004 Sep-Oct;10(9-10):1502-9. doi: 10.1089/ten.2004.10.1502. Tissue Eng. 2004. PMID: 15588409 - Modification of collagen matrices for enhancing angiogenesis.
Yao C, Prével P, Koch S, Schenck P, Noah EM, Pallua N, Steffens G. Yao C, et al. Cells Tissues Organs. 2004;178(4):189-96. doi: 10.1159/000083730. Cells Tissues Organs. 2004. PMID: 15812146 - Tissue substitutes with improved angiogenic capabilities: an in vitro investigation with endothelial cells and endothelial progenitor cells.
Grieb G, Groger A, Piatkowski A, Markowicz M, Steffens GC, Pallua N. Grieb G, et al. Cells Tissues Organs. 2010;191(2):96-104. doi: 10.1159/000231473. Epub 2009 Jul 28. Cells Tissues Organs. 2010. PMID: 19641290 - Type I collagen and collagen mimetics as angiogenesis promoting superpolymers.
Twardowski T, Fertala A, Orgel JP, San Antonio JD. Twardowski T, et al. Curr Pharm Des. 2007;13(35):3608-21. doi: 10.2174/138161207782794176. Curr Pharm Des. 2007. PMID: 18220798 Review.
Cited by
- Collagen Type I Biomaterials as Scaffolds for Bone Tissue Engineering.
Rico-Llanos GA, Borrego-González S, Moncayo-Donoso M, Becerra J, Visser R. Rico-Llanos GA, et al. Polymers (Basel). 2021 Feb 17;13(4):599. doi: 10.3390/polym13040599. Polymers (Basel). 2021. PMID: 33671329 Free PMC article. Review. - Anchorage of VEGF to the extracellular matrix conveys differential signaling responses to endothelial cells.
Chen TT, Luque A, Lee S, Anderson SM, Segura T, Iruela-Arispe ML. Chen TT, et al. J Cell Biol. 2010 Feb 22;188(4):595-609. doi: 10.1083/jcb.200906044. J Cell Biol. 2010. PMID: 20176926 Free PMC article. - Collagen-Based Tissue Engineering Strategies for Vascular Medicine.
Copes F, Pien N, Van Vlierberghe S, Boccafoschi F, Mantovani D. Copes F, et al. Front Bioeng Biotechnol. 2019 Jul 12;7:166. doi: 10.3389/fbioe.2019.00166. eCollection 2019. Front Bioeng Biotechnol. 2019. PMID: 31355194 Free PMC article. Review. - Establishment and characterization of a squamous cell carcinoma cell line, designated hZK-1, derived from a metastatic lymph node tumor of the tongue.
Hirabayashi T, Takahashi H, Watanabe M, Tachibana T. Hirabayashi T, et al. Hum Cell. 2017 Oct;30(4):319-326. doi: 10.1007/s13577-017-0165-y. Epub 2017 Mar 4. Hum Cell. 2017. PMID: 28260147 - Bioactive scaffolds for engineering vascularized cardiac tissues.
Chiu LL, Radisic M, Vunjak-Novakovic G. Chiu LL, et al. Macromol Biosci. 2010 Nov 10;10(11):1286-301. doi: 10.1002/mabi.201000202. Macromol Biosci. 2010. PMID: 20857391 Free PMC article.
References
- Int J Dev Biol. 1996 Dec;40(6):1189-97 - PubMed
- J Biomed Mater Res A. 2003 Oct 1;67(1):61-8 - PubMed
- World J Urol. 2000 Feb;18(1):10-8 - PubMed
- J Mater Sci Mater Med. 2002 Nov;13(11):1029-35 - PubMed
- J Mater Sci Mater Med. 2001 Mar;12(3):195-9 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources